Helping teens and young adults choose menstrual care and birth control
Official title: Improving Shared Decision-Making in Menstrual Management and Contraception for Adolescents and Young Adults: A Cluster-Randomized Trial
Run by University Hospital, Geneva · NCT07320651 · Data updated 2026-11-12
This project will try an Encounter Decision Aid to help adolescents and young adults (ages 12–25) make decisions about menstrual management and contraception during outpatient visits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 25 Years |
| Sex | Women only |
| Enrollment | 252 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Geneva, Canton of Geneva) |
| Status | Recruiting |
| Started | September 2, 2025 |
| Main results expected | October 2027 |
| Study ends | January 2028 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT07320651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents and young adults aged 12–25 who present to the specified outpatient gynecology clinics at Geneva University Hospitals and are considering starting or switching hormonal medication for menstrual management or contraception, and who can provide informed consent in French, are ideal candidates.
✕Probably not a fit
Patients who cannot read or understand French, have major sensory or cognitive impairments that preclude using the decision aid without a guardian, or who are not considering hormonal options are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This cluster-randomized trial compares an Encounter Decision Aid (EDA) to standard counseling for adolescents and young adults considering initiation or switching of hormonal treatments for menstrual management or contraception at Geneva University Hospitals. Clinics or providers are randomized to use the EDA during consultations or to continue usual counseling, and patient-centered outcomes such as decision quality, decisional conflict, and satisfaction are measured. The EDA was developed following International Patient Decision Aid Standards and the Ottawa Decision Support Framework to present evidence-based options and support shared decision-making. Participants must be able to understand French and give informed consent or be accompanied by a legal guardian where required.
Why it matters
Potential benefit: If successful, the tool could help young patients make clearer, more informed choices that align with their preferences and improve satisfaction with care.
How similar studies have gone: Decision-aid interventions in contraceptive and other preference-sensitive decisions have previously improved knowledge and reduced decisional conflict, although evidence specifically focused on adolescent menstrual management is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adolescents and young adults aged 12-25 years old * presenting to an outpatient consultation at "Unité de policlinique de gynécologie" or "Consultation de gynécologie pédiatrique" at HUG * considering initiation or switch to hormonal medication for menstrual management and/or contraception * able to give informed consent as documented by signature or accompanied by a legal guardian who can provide consent if required. Exclusion Criteria: * individuals who cannot read and understand French to a degree that would prevent participation in informed consent and study-related materials. * individuals who have major sensory disability, such as visual or hearing impairment, that would compromise their ability to give written informed consent and use the EDA, in the absence of their legal guardian. * individuals with cognitive or psychiatric conditions significantly impairing decision making capacity, unless accompanied by a legal guardian. * patients currently participating in another clinical trial related to contraceptive decision-making, to avoid potential interference.
Where it's running
-
Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland Recruiting
Study contacts
- Study coordinator: Dehlia Moussaoui
- Email: dehlia.moussaoui@hug.ch
- Phone: +41 22 372 33 87
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of the Natural Cycles birth control app
This study will test how well the Natural Cycles app prevents pregnancy over one year in sexually active women aged 18 to 35 with no known infertility.
-
Female Reproductive Health in the Canadian Armed Forces: Understanding Issues from Contraception to Pelvic Floor Dysfunction
This observational study looks at reproductive health among women in the Canadian Armed Forces to see how contraception, pregnancy outcomes, infertility, pelvic floor issues, and related factors affect service members and veterans.
-
Long-acting HIV PrEP and contraception PK study in AGYW
This study tests how long-acting cabotegravir for PrEP interacts with hormonal contraception in young women.
-
Vasectomy: Right for Me? — a web-based decision aid
A web-based decision aid helps men think clearly about vasectomy and other birth control options to see if it fits their goals.
-
Contraceptive patch designed to stop ovulation
This trial tests whether a norelgestromin transdermal patch can keep ovulation suppressed for 84 days even when users make intentional application mistakes, in healthy women aged 18–35.
-
Mittin intervention to improve contraceptive side effect counseling and follow-up in Addis Ababa
Aims to see if the Mittin program helps women who use hormonal methods or copper IUDs in Addis Ababa better manage their contraception according to their preferences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.